Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,130.00
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.49
(
-0.16%
)
Bitcoin
73,917.45
(
-0.03%
)
News Focus
News Focus
Post# of 446785
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (6) Keep Next 10 Report Keyboard Shortcuts
Replies (6) Next 10 Prev Next

JRoon71

Send PM Follow Ignore
Followers 22
Posts 4584
Boards Moderated 0
Alias Born 01/27/2022

JRoon71

Re: Number sleven post# 441130

Friday, 11/14/2025 2:11:05 PM

Friday, November 14, 2025 2:11:05 PM

Post# of 446785
Sichuan Guowei, Shandong Xinhua, and Qilu were approved on January 31, 2023, May 27, 2025, and June 30, 2025, respectively.

Yiteng Pharmaceutical (Suzhou) Co., Ltd. received approval for Vascepa. I think EddingPharm is a division of Yiteng (or vice versa). Or they are somehow related.

They received approvals in 06/23 for VHTG and 06/24 for CVRR
Public Reply Private Reply New Post
Keep Last Read
Replies (6) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (6) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM

Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM

Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM

Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM

DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM

Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM

Start posting your company's news
Only $200 per official company press release!